Cambridge Investment Research Advisors Inc. Increases Position in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Cambridge Investment Research Advisors Inc. boosted its holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 6.1% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 64,090 shares of the company’s stock after purchasing an additional 3,698 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $955,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of BMEZ. Janney Montgomery Scott LLC raised its position in shares of BlackRock Health Sciences Term Trust by 9.7% in the first quarter. Janney Montgomery Scott LLC now owns 30,163 shares of the company’s stock valued at $449,000 after buying an additional 2,668 shares during the last quarter. Rockefeller Capital Management L.P. raised its holdings in BlackRock Health Sciences Term Trust by 62.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 118,445 shares of the company’s stock valued at $1,706,000 after acquiring an additional 45,616 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in shares of BlackRock Health Sciences Term Trust in the fourth quarter worth approximately $10,869,000. Corient Private Wealth LLC raised its holdings in shares of BlackRock Health Sciences Term Trust by 24.9% in the 4th quarter. Corient Private Wealth LLC now owns 26,225 shares of the company’s stock worth $378,000 after purchasing an additional 5,224 shares during the period. Finally, Commonwealth Equity Services LLC grew its stake in shares of BlackRock Health Sciences Term Trust by 3.7% in the fourth quarter. Commonwealth Equity Services LLC now owns 102,437 shares of the company’s stock valued at $1,475,000 after buying an additional 3,635 shares in the last quarter.

BlackRock Health Sciences Term Trust Trading Down 0.1%

BMEZ stock opened at $14.46 on Friday. The firm has a fifty day moving average price of $14.44 and a two-hundred day moving average price of $14.90. BlackRock Health Sciences Term Trust has a 1-year low of $12.58 and a 1-year high of $16.75.

BlackRock Health Sciences Term Trust Cuts Dividend

The firm also recently declared a monthly dividend, which will be paid on Thursday, July 31st. Investors of record on Tuesday, July 15th will be given a dividend of $0.1672 per share. This represents a $2.01 annualized dividend and a yield of 13.88%. The ex-dividend date of this dividend is Tuesday, July 15th.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.